Annexon, Inc.

formerly Annexon BiosciencesIPO

Unlocking the next generation of complement therapies

Public · South San Francisco, United States · Founded 2016 · $278.0M raised

Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$278.0M
Last Round
Series ENov 2025
Rounds
9
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 11 funding rounds and 16 investors for this company. The full record is or through the API.

About

Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines targeting the classical complement pathway via C1q inhibition. Its pipeline addresses autoimmune, neurodegenerative, and ophthalmic disorders, with candidates including ANX005, ANX007, and ANX009 in clinical development. The company was founded in 2011 by Arnon Rosenthal and Ben Barres.

Summary

Annexon, Inc. is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $278.0M in total across 9 rounds, most recently a Series E round in Nov 2025. Investors include GV, Alta Partners and Satter Investment.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Series ESeries ENov 2025

Sign up to see all 11 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Annexon, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/annexon-inc"><img src="https://indexed.vc/api/badge/company/annexon-inc" alt="Annexon, Inc. on Indexed.vc" width="260" height="76" /></a>